Navigation Links
RPA in Medical News

PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

...velopment programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Third generation rpa anthrax vaccine Valortim((R)) - a fully human monoclonal antibody for the prevention and treatment of anthrax infection Protexia((R)) - a ...

Renal Physicians Association Participates in PEAK Campaign

...d Accountability in Kidney Care (PEAK) initiative. rpa is a member of KCP, a coalition which includes gro...mmend KCP for launching the PEAK initiative," said rpa President Dr. Edward Jones. "While the evidence b... in the overall improvement of CKD care quality." rpa has developed evidence-based clinical practice gui...

PharmAthene Reports Year End 2008 Financial Results

...t contracts supporting the development of SparVax(TM), our third generation rpa anthrax vaccine candidate, and RypVax(TM). Research and development ex... - a recombinant dual antigen vaccine for plague A third generation rpa anthrax vaccine. For more information about PharmAthene, ...

The Renal Physicians Guide to Nephrology Practice, 6th Edition

...nsure quality care under the highest standards of medical practice for patients with kidney disease and related disorders. For more information about rpa please visit www.renalmd.org or call 301-468-3515. ...

Cogdell Spencer Breaks Ground on Projects in Tennessee and North Carolina

...cian groups. Erdman is the developer on the project, Robins & Morton of Birmingham, Alabama is the general contractor on this project while rpa Design, based in Charlotte, North Carolina, is the project architect on both the Tennessee and Mebane projects. Upon completion, Cogdell Spencer Inc....

Renal Physicians Association 2009 Annual Meeting

...and relevant to today's nephrology practitioners. rpa will convene national leaders and experts in their... Beyond the rich and pertinent content that the rpa meeting offers, this unique venue allows nephrolog...rapple with every day. Register today for the 2009 rpa Annual Meeting March 20-23 in Baltimore, Maryland ...

Iomai Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine

... UK site has been developing processes and making protein-based biopharmaceuticals to cGMP since 1998. Process development and cGMP manufacture of the rpa anthrax vaccine and the plague vaccine have been carried out at this site since 2000. Avecia Biotechnology Inc. is a leader in the field of contract m...

More>>

RPA in Medical Technology

PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program

ANNAPOLIS, Md., April 28 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it will be hosting a conference call for investors on Wednesday, April 29th beginning at ...

PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)

...tality associated with exposure to chemical nerve agents RypVax(TM) - a recombinant dual antigen vaccine for plague A third generation rpa anthrax vaccine. For more information about PharmAthene, please visit www.PharmAthene.com . Statement on Cautionary Factors ...

PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA

... and procure 25 million doses of a next generation rpa anthrax vaccine for the country's civilian biomedi...ced development and procurement of next generation rpa anthrax vaccines." About SparVax(TM) Spar...gen (rPA) anthrax vaccine Third generation rpa anthrax vaccine Valortim(R) - a fully huma...

Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology

...tality associated with exposure to chemical nerve agents RypVax(TM) - a recombinant dual antigen vaccine for plague A third generation rpa anthrax vaccine. For more information about PharmAthene, please visit www.PharmAthene.com . Statement on Cautionary Factors ...

PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)

...t development programs include: -- SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine -- Third generation rpa anthrax vaccine -- Valortim(R) - a fully human monoclonal antibody for the prevention and treatment of anthrax infection -- Protexia(R) - a nove...

PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop

... development programs include: -- SparVax(TM) -- a second generation recombinant protective antigen (rPA) anthrax vaccine -- Third generation rpa anthrax vaccine -- Valortim(R) -- a fully human monoclonal antibody for the prevention and treatment of anthrax infection -- Protexia(R) -- a no...

ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.

...s rPA102 anthrax vaccine is composed of a purified rpa and an aluminum salt adjuvant routinely used in ma...l be mirrored in testing of Viprovex with VaxGen's rpa antigen." Initial studies in a well-established m...chael Wilhelm. "With the previous success that the rpa vaccine has seen in the lab against anthrax we are...
RPA in Biological News

Kidney function discovery sheds light on genetic complexity of disease

... due to an inherited abnormality of a specific pump on the surface of kidney cells," Professor Rasko explains. The teams from Centenary Institute, rpa and ANU have now unravelled the genetic explanation by showing that not one, but up to four different pumps present in the kidney determine whether or...

DNA ends: Common tool, different job

... Stn1, they dug up Rpa2, the middle subunit of the rpa complex. In particular, Stn1 and Rpa2 share simila...e just like their counterparts in the conventional rpa complex. However, Stn1 and Ten1 have the same pred...tial biological parallels between the conventional rpa complex and the newly discovered t-RPA complex. ...
RPA in Biological Technology

PharmAthene's 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review

ANNAPOLIS, Md., July 9 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Company's propos...

PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program

ANNAPOLIS, Md., Sept. 26 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Inst...

PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009

...elopment programs include: SparVax(TM) -- a second generation recombinant protective antigen (rPA) anthrax vaccine Third generation rpa anthrax vaccine Valortim((R)) -- a fully human monoclonal antibody for the prevention and treatment of anthrax infection Protexia((R)) -- ...

PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

... programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Third generation rpa anthrax vaccine Valortim(R) - a fully human monoclonal antibody for the prevention and treatment of anthrax infection Pr...

PharmAthene Reports First Quarter 2009 Financial and Operational Results

... activities related to the SparVax(TM), RypVax(TM) and our third generation rpa anthrax vaccine programs, which we acquired in the second quarter of 2008. ...combinant protective antigen (rPA) anthrax vaccine Third generation rpa anthrax vaccine Valortim(R) - a fully human monoclonal antibody for...

PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research

...t programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Third generation rpa anthrax vaccine Valortim(R) - a fully human monoclonal antibody for the prevention and treatment of anthrax infection Protexia(R) - a ...

PharmAthene Announces $5.5 Million Public Equity Offering

...t programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Third generation rpa anthrax vaccine Valortim(R) - a fully human monoclonal antibody for the prevention and treatment of anthrax infection Protexia(R) - a ...

PharmAthene To Host Year-End 2008 Earnings Conference Call and Webcast on Monday, March 30, 2009

...t programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Third generation rpa anthrax vaccine Valortim(R) - a fully human monoclonal antibody for the prevention and treatment of anthrax infection Protexia(R) - a ...

PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting

...These results suggest that SparVax(TM) may be a promising second generation rpa anthrax vaccine candidate for civilian defense against anthrax infection. ...combinant protective antigen (rPA) anthrax vaccine Third generation rpa anthrax vaccine Valortim(R) - a fully human monoclonal antibody for...

PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel

...opment programs include: -- SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine -- Third generation rpa anthrax vaccine -- Valortim(R) - a fully human monoclonal antibody for the prevention and treatment of anthrax infection -- Protexia(R...

More>>

RPA in Biological Dictionary

Primase

...subunits, which catalyzes the ... ... DnaB Helicase and Its Complex with a Domain of DnaG Primase [My Copy] ... posted to atr primase rad17 rfc rpa by DNAReplication on 2008-01-02 18:45:20 as ... The European ... DNA primase synthesizes the RNA primers for the Okazaki ... In Escherichia coli,...
Other Tags
(Date:7/31/2014)... 31, 2014 In its latest blog post, ... believes that having family close by during a stay in ... the process is successful, is looking at 10 tips to ... , “Addiction recovery is a lifelong process, and one that ... committed to without compromise,” commented Best Drug Rehabilitation’s CEO ...
(Date:7/31/2014)... 2014 The study, The Truth ... Medicare episode of care payments for four clinical areas—congestive ... joint replacements (hips and knees). Using the definition ... for Care Improvement program, the study examines these clinical ... in the country. , “Our study reaffirms that, in ...
(Date:7/30/2014)... The Mesothelioma Applied Research Foundation ... Center, will host a regional conference on ... field of mesothelioma. September 26 marks the National Mesothelioma ... the public, and specifically aimed at mesothelioma patients, family ... exposed to asbestos. , The conference will take place ...
(Date:7/30/2014)... Regardless of traumatic events experienced during deployment, returning ... a drinking problem if faced with civilian life ... serious financial and legal problemsall commonplace in military ... Columbia University,s Mailman School of Public Health are ... Preventive Medicine . , Alcohol abuse is a ...
(Date:7/30/2014)... “United States Orthopedic Braces and Supports Market Outlook to 2020?, ... and Supports market. The report provides value, in millions of ... (in US dollars), within market categories:, ... Supports , Spinal Braces and Supports , ... is a specialty within the medical field concerned with the ...
Breaking Medicine News(10 mins):Health News:New Best Drug Rehabilitation Blog Posts Looks at 10 Tips for Coping After Drug or Alcohol Rehab 2Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 2Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 3Health News:September Events: Regional Conference on Mesothelioma in Philadelphia 2Health News:September Events: Regional Conference on Mesothelioma in Philadelphia 3Health News:Vets' alcohol problems linked to stress on the home front 2Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 2Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 3Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 4
(Date:7/30/2014)... , July 30, 2014 NexID ... and liveness detection solutions for the biometric authentication ... industry consortium revolutionizing online authentication with standards for ... Cornett , "The decision to join FIDO Alliance ... authentication pervasive in use. We believe the FIDO ...
(Date:7/30/2014)... To help Americans make better decisions about what they ... year proposed significant changes to the Nutrition Facts label ... An article in Chemical & Engineering News ... Society, explains the suggested updates and the fight ... at C&EN, points out that while the Nutrition Facts ...
(Date:7/30/2014)... Chown has been awarded the Scientific Committee on ... Antarctic Research. , SCAR, an inter-disciplinary international science ... scientific research in the Antarctic region, and on ... Earth system. The organisation also provides scientific advice ... for governing the region. , The medal is ...
Breaking Biology News(10 mins):NexID Biometrics Joins the FIDO Alliance 2
Other Contents